TP53 and cancer: Loss and/or perturbation of cell-cycle control checkpoints results in genomic instability and is a hallmark of cancer, as evidenced by the common association of polymorphisms/inactivation of cell-cycle control genes such as p53, p16 and Rb1, with various types of cancer (19,20).